Rivaroxaban

IUPAC name:

5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide

CAS No.

366789-02-8

Molecular Weight:

435.88g.mol−1

Molecular Formula:

C19H18ClN3O5S

Granule:

Available-Ready to press

Mechanism Of Action:

It’s a selective inhibitor of factor Xa (FXa), and is an inhibitor of free FXa and prothrombinase activity, and indirectly inhibits platelet aggregation induced by thrombin.

Indication:

Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation (NVAF)
Treatment of Deep Vein Thrombosis (DVT) & Pulmonary Embolism (PE)
Reduction in the Risk of Recurrence of DVT and/or PE
Prophylaxis of DVT Following Hip or Knee Replacement Surgery
Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Patients at Risk for Thromboembolic Complications Not At High Risk of Bleeding
Reduction of Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)
Treatment of venous thromboembolism, and Prophylaxis of recurrent venous thromboembolism in in pediatric patients.

information

Category: Cardiovascular

January 21, 2024

Desloratadine

Anti-Histamine

Cas No: 100643-71-8

Mechanism Of Action: Desloratadine is a non-sedating, long-acting antihistamine that selectively blocks peripheral histamine H1-receptors. It is the major active metabolite of loratadine and works

Voriconazole

Anti-Microbial

Cas No: 137234-62-9

Mechanism Of Action: Voriconazole is a triazole antifungal agent that works by inhibiting the fungal cytochrome P450 enzyme 14-alpha-lanosterol demethylase1. This enzyme is crucial for

Enoxaparin Sodium

Cardiovascular

Cas No: 679809-58-6

Mechanism Of Action: Enoxaparin, a low molecular weight heparin (LMWH), works primarily by activating antithrombin III, which in turn inhibits factor Xa and IIa (thrombin).

Tirzapatide

Anti-Diabetic

Cas No: 2023788-19-2

Mechanism Of Action : Tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This means it mimics the

Lenvatinib Mesylate

Oncology

Cas No: 857890-39-2

Mechanism Of Action: Lenvatinib is classified as a receptor tyrosine kinase (RTK) inhibitor that effectively suppresses the kinase activities of vascular endothelial growth factor (VEGF)

TRAMETINIB DIMETHYL SULFOXIDE

Oncology

Cas No: 1187431-43-1

Mechanism Of Action: Trametinib is identified as a reversible and remarkably selective allosteric inhibitor of MEK1 and MEK2. Through its high-affinity binding to unphosphorylated MEK1